BELITE BIO INC SPONSORED ADS is a security (CUSIP 07782B104) tracked across SEC portfolio filings. 77 institutional managers reported $1.4B on Form 13F as of 2026-06-30; 3 registered fund positions totaling $35.7M via N-PORT as of 2026-05-31.
Showing 15 of 77 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Darwin Global Management, Ltd. | ST. HELIER, Y9 | $456.1M | 3,057,412 |
| Paradigm Biocapital Advisors LP | NEW YORK, NY | $177.7M | 1,114,784 |
| UBS Group AG | Zurich, V8 | $122.5M | 768,359 |
| RTW INVESTMENTS, LP | NEW YORK, NY | $114.1M | 715,332 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $90.9M | 570,088 |
| Holocene Advisors, LP | New York, NY | $78.8M | 494,495 |
| EVENTIDE ASSET MANAGEMENT, LLC | Boston, MA | $57.0M | 357,650 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | New York, NY | $48.5M | 304,013 |
| MORGAN STANLEY | NEW YORK, NY | $32.1M | 201,409 |
| PERCEPTIVE ADVISORS LLC | NEW YORK, NY | $24.2M | 151,979 |
| Patient Square Capital LP | Menlo Park, CA | $18.6M | 116,684 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $16.8M | 105,509 |
| MPM BIOIMPACT LLC | BOSTON, MA | $14.0M | 88,045 |
| Affinity Asset Advisors, LLC | New York, NY | $10.4M | 65,000 |
| FRED ALGER MANAGEMENT, LLC | NEW YORK, NY | $10.0M | 62,574 |
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $33.1M | 30.42% |
| T. Rowe Price Health Sciences Portfolio | T. ROWE PRICE EQUITY SERIES, INC. | $2.0M | 30.56% |
| Fidelity Nasdaq Composite Index ETF | Fidelity Commonwealth Trust | $538K | 0.49% |